CT
MRNA icon

Cambridge Trust’s Moderna MRNA Stock Holding History

Cambridge Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$35.6K Hold
334
– – ﹤0.01% 464
2023
Q4 		$33.2K Sell
334
-200
-37% -$16.8K ﹤0.01% 459
2023
Q3 		$55.2K Hold
534
– – ﹤0.01% 403
2023
Q2 		$64.9K Sell
534
-12
-2% -$1.6K ﹤0.01% 404
2023
Q1 		$83.9K Hold
546
– – ﹤0.01% 378
2022
Q4 		$98K Hold
546
– – ﹤0.01% 373
2022
Q3 		$65K Hold
546
– – ﹤0.01% 420
2022
Q2 		$78K Hold
546
– – ﹤0.01% 424
2022
Q1 		$94K Sell
546
-124
-19% -$20.9K ﹤0.01% 435
2021
Q4 		$170K Buy
670
+125
+23% +$36.5K 0.01% 353
2021
Q3 		$210K Buy
+545
New +$201K 0.01% 263

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cambridge Trust's MRNA Position: Q1 2024 in Review

Cambridge Trust held its Moderna (MRNA) position steady in Q1 2024 at 334 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #464.

Cambridge Trust first reported a position in MRNA in Q3 2021 and has held it in 11 quarters since. The position peaked at $210K in Q3 2021. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Cambridge Trust held 334 shares of Moderna worth $35.6K as of Q1 2024.
  • Cambridge Trust left its Moderna share count unchanged in Q1 2024.
  • Moderna made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #464 holding.
  • Cambridge Trust first reported a position in Moderna in Q3 2021 and has held it in 11 quarters since.
  • Cambridge Trust's Moderna position peaked at $210K in Q3 2021.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.